PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 123 filers reported holding PROVENTION BIO INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,319,288 | +137.3% | 96,236 | +4.1% | 0.00% | +50.0% |
| Q4 2022 | $977,418 | +209.3% | 92,471 | +31.9% | 0.00% | +100.0% |
| Q3 2022 | $316,000 | +14.5% | 70,129 | +1.5% | 0.00% | – |
| Q2 2022 | $276,000 | -42.1% | 69,112 | +6.0% | 0.00% | -100.0% |
| Q1 2022 | $477,000 | +20.2% | 65,229 | -7.6% | 0.00% | – |
| Q4 2021 | $397,000 | -10.0% | 70,576 | +2.5% | 0.00% | -100.0% |
| Q3 2021 | $441,000 | -31.6% | 68,885 | -9.9% | 0.00% | 0.0% |
| Q2 2021 | $645,000 | -23.2% | 76,470 | -4.5% | 0.00% | 0.0% |
| Q1 2021 | $840,000 | -31.1% | 80,035 | +11.1% | 0.00% | -50.0% |
| Q4 2020 | $1,220,000 | +32.0% | 72,036 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $924,000 | +2.4% | 72,036 | +12.7% | 0.00% | -50.0% |
| Q2 2020 | $902,000 | – | 63,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |